Tirofiban recalls

The FDA has published 2 recalls involving Tirofiban since 2025. The latest was reported on 7 May 2025. Most were for potency & assay. Recalls usually affect specific lots, not every bottle on the market. Check the lot number on each recall page before acting.

Total recalls2since 2025
Last 12 months0reported
Class I00% of total
Ongoing2latest 7 May 2025

Recalls per month, last 24 months

click a bar for that month

Severity split

Class I 0 0%Class II 2 100%Class III 0 0%

Why tirofiban is recalled

Companies

By year

Ongoing tirofiban recalls

2 active
ReportedClassRecallCompanyReasonWhere
DrugCLASS IITirofiban Hydrochloride Injection 5 mg recalled by Eugia USTirofibanEugia USPotency & AssayNationwide
DrugCLASS IITirofiban Hydrochloride Injection 5 mg recalled by Eugia USTirofibanEugia USPotency & AssayNationwide

All tirofiban recalls, newest first

2 total
ReportedClassRecallCompanyReasonWhere
DrugCLASS IITirofiban Hydrochloride Injection 5 mg recalled by Eugia USTirofibanEugia USPotency & AssayNationwide
DrugCLASS IITirofiban Hydrochloride Injection 5 mg recalled by Eugia USTirofibanEugia USPotency & AssayNationwide

Should you stop taking Tirofiban?

Not on your own. Most recalls affect specific lots from one manufacturer, and stopping a prescription suddenly can be riskier than the defect. Check your lot number and NDC against the recall, then call the pharmacy that dispensed it for a replacement.